CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $109,000 | +473.7% | 10,498 | +118.9% | 0.00% | – |
| Q3 2019 | $19,000 | -70.8% | 4,795 | +11.4% | 0.00% | – |
| Q2 2019 | $65,000 | -15.6% | 4,306 | +36.9% | 0.00% | -100.0% |
| Q1 2019 | $77,000 | +156.7% | 3,146 | +93.4% | 0.00% | – |
| Q4 2018 | $30,000 | +66.7% | 1,627 | +165.0% | 0.00% | – |
| Q3 2018 | $18,000 | -86.7% | 614 | -75.9% | 0.00% | -100.0% |
| Q2 2018 | $135,000 | 0.0% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $135,000 | +4400.0% | 2,550 | +5000.0% | 0.00% | – |
| Q4 2017 | $3,000 | -76.9% | 50 | -69.5% | 0.00% | – |
| Q3 2017 | $13,000 | -93.3% | 164 | -92.1% | 0.00% | -100.0% |
| Q2 2017 | $194,000 | +41.6% | 2,077 | -3.4% | 0.00% | 0.0% |
| Q1 2017 | $137,000 | +28.0% | 2,150 | -10.4% | 0.00% | +100.0% |
| Q4 2016 | $107,000 | +48.6% | 2,400 | +20.0% | 0.00% | 0.0% |
| Q3 2016 | $72,000 | +7100.0% | 2,000 | +15284.6% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 13 | +30.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -91.7% | 10 | -95.2% | 0.00% | – |
| Q4 2014 | $12,000 | +20.0% | 210 | 0.0% | 0.00% | – |
| Q3 2014 | $10,000 | -95.4% | 210 | -96.0% | 0.00% | -100.0% |
| Q2 2014 | $216,000 | – | 5,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |